AIB1 has been implicated in several cancers [18, 19], and attenuation of AIB1 frequently inhibits the activation of Akt signaling by suppressing the expression of insulin receptor substrate (IRS)-1 and IRS-2 [20–22]. This evidence concerns the gene NCOA3 and cancer.